Cointime

Dexcom

company

About

Dexcom develops, manufactures, and distributes continuous glucose monitoring systems for diabetes management.

Highlights

Stock Symbol
nasdaq:DXCM
Total Funding Amount
$470.08M
Funding Rounds
6
Investors
7
Investments
2
Lead Investments
1

Details

Last Funding Type
Post-IPO Equity
Last Funding Money Raised
$7.22M
Industries
Biotechnology,Health Care,Manufacturing,Medical Device
Founded date
Jan 1, 1999
Number Of Employee
5001 - 10000
Operating Status
Active
Stock Symbol
nasdaq:DXCM
Legal Name
DexCom, Inc.

DexCom, Inc. is a leader in continuous glucose sensing technologies, and focuses 100% on these technologies. Founded in 1999, DexCom’s roots stem from the pioneering 1967 research on implanted glucose sensors at the University of Wisconsin. DexCom started with a focus on creating an implantable Sensor that the body would not reject and that would perform for a long period of time.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
6
$470.08M
Dexcom has raised a total of $470.08M in funding over 2 rounds. Their latest funding was raised on May 9, 2017 from a Post-IPO Debt round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 9, 2017 Post-IPO Debt $350M — — — Detail
May 2, 2016 Post-IPO Equity $7.22M — — — Detail
Apr 12, 2012 Post-IPO Equity $3.96M — — — Detail
Apr 14, 2005 IPO $56.40M — — — Detail
Jan 6, 2005 Series D $22.50M 4 — — Detail
Show More

Investments

Number of Investments
Number of Lead Investments
2
1
Dexcom has made 2 investments. Their most recent investment was on Jun 17, 2020, when Current Health raised £3.32M.
Date Company Name
Round Money Raised Industry Lead Investor
Jun 17, 2020 Current Health
Series A £3.32M Health Care Yes
Jan 8, 2019 Beta Bionics
Series B $63M Biotechnology —

Investors

Number of Lead Investors
Number of Investors
1
7
Dexcom is funded by 7 investors. Canaan Partners and RWI Group are the most recent investors.
Investor Name Lead Investor Funding Round
Canaan Partners — Series D
RWI Group — Series D
St. Paul Venture Capital — Series D
Warburg Pincus — Series D
Federated Kaufmann Fund — Series C
Fog City Capital — Series C
Windamere Venture Partners — Series C

Employee Profiles

Number of Employee Profiles
17
Dexcom has 17 current employee profiles, including Board member Jonathan Lord
Jonathan Lord
Board member
Teri Lawver
Executive
Nick Augustinos
Board member
Groff Bittner
Employee
Nate Heintzman
Employee
Show More

Exits

Dexcom has had 1 exits. Dexcom most notable exits include Current Health

Date Company Name Exit Type Industry
Oct 12, 2021 Current Health M&A Health Care Detail

Acquisition

Dexcom has acquired 3 organizations. Their most recent acquisition was SweetSpot Diabetes Care on Feb 29, 2012. They acquired SweetSpot Diabetes Care for $8.50M.

Date Company Name
Industry Acquisition Type Price
Feb 29, 2012 SweetSpot Diabetes Care
Analytics — $ 8.50M Detail
May 2, 2016 Nintamed
Information Technology acquisition — Detail
Aug 22, 2018 TypeZero Technologies
Cloud Computing acquisition — Detail
Cointime
เนื้อหา
บริษัท